Ferric Citrate Anhydrous

CHEMBL3991241 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
244.9 g/mol
LogP
Phase
4

This is a water-free form of ferric citrate, an iron-based phosphate binder used to manage elevated phosphate levels in patients with kidney disease. It also helps replenish iron stores as a secondary benefit during treatment.

Moleküler Ağırlık

244,9400 g/mol

TPSA

141,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+3]

InChI

InChI=1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3

Molecular Formula

C6H5FeO7

HBD / HBA

1 / 7

Döndürülebilir Bağlar

2

Ağır Atomlar

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This is a water-free form of ferric citrate, an iron-based phosphate binder used to manage elevated phosphate levels in patients with kidney disease. It also helps replenish iron stores as a secondary benefit during treatment.

Yes, Ferric Citrate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3991241. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 61300. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.